Atlas Trials

Predictive Factors of Clinical Response to Ustekinumab in Active Crohn's Disease

Clinical trial NCT03351647 · COMPLETED

Trial details

NCT number
NCT03351647
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Study type
OBSERVATIONAL
Crohn Disease
Start date
2018-02-14
Primary completion
2018-08-29
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.